Positive PEGASUS-TIMI 54 Study With Ticagrelor (Brilinta)Positive PEGASUS-TIMI 54 Study With Ticagrelor (Brilinta)

Announced today, the study met its primary end point, a composite of cardiovascular death, nonfatal MI, or nonfatal stroke, and is expected to be presented at a meeting in 2015. Heartwire

Source: Medscape Medical News Headlines - January 14, 2015 Category: Consumer Health News Tags: Cardiology News Source Type: news